AstraZeneca Starts Patent Squabble With IVAX
In a move to fend off a rival's attempts to produce and market a generic form of Nexium, AstraZeneca AB has fired off a lawsuit against drug maker IVAX Corporation for...To view the full article, register now.
Already a subscriber? Click here to view full article